Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer-Reference-Cited by-同舟云学术

Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer

Published:2022-11-22 Issue:22 Volume:7 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Heiduk Max^ORCID,Plesca Ioana,Glück Jessica,Müller Luise,Digomann David^ORCID,Reiche Charlotte,von Renesse Janusz^ORCID,Decker Rahel,Kahlert Christoph,Sommer Ulrich,Aust Daniela E.,Schmitz Marc,Weitz Jürgen,Seifert Lena,Seifert Adrian M.^ORCID

Funder

Ernst-Jung Stiftung

Monika Kutzner Stiftung

German Research Foundation

German Cancer Consortium

Medical Faculty Carl Gustav Carus Technische Universität Dresden

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/152761/files/pdf

Reference46 articles.

1. Cancer Statistics, 2021

2. Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions

3. Optimizing the outcomes of pancreatic cancer surgery

4. Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages

5. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and future immunotherapeutic approaches in pancreatic cancer treatment;Journal of Hematology & Oncology;2024-06-04

2. Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma;Frontiers in Immunology;2024-04-02

3. Single Dual-specific Anti-PD-L1/TGF-β Antibody Synergizes with Chemotherapy as Neoadjuvant Treatment for Pancreatic Ductal Adenocarcinoma: a Preclinical Experimental Study;International Journal of Surgery;2024-03-14

4. Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translation;Journal of Controlled Release;2024-03

5. Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer;npj Precision Oncology;2023-10-14